Skip to content
Research Article Open access CC BY 4.0

Formulation, in vitro and Bioavailability Assessments of Ranitidine Rectal Suppositories

Khaled Shalaby, Ahmed M. Samy, Alaa Kassem, Mohamed F. Ibrahim, Nabil K. Alruwaili, Hazim M. Ali, Mohammed Elmowafy

Journal of Pharmaceutical Research International · pp. 1–10 · Published 10 Oct 2019

10.9734/jpri/2019/v30i130262

Abstract

The objective of the current work was to develop and evaluate suppository dosage form in order to improve ranitidine bioavailability as a substitute to the oral administration. Suppocire (different grades), Witepsol W25 and polyethylene glycol (PEG) were used as suppository bases and prepared by molding method. The prepared formulations were examined for hardness, disintegration time, melting point, content uniformity, drug release, stability and bioavailability. The hardness ranged from 3.82 to 12.53 kg and disintegration time from 13.32 to 28.22 min. The melting points of fatty bases had values from 33.94 to 36.82±0.36ºC while PEG based suppositories melting points were directly proportional chain length. Higher content uniformity was observed in PEG based suppositories due to easy incorporation of RT into water soluble base. Release was affected by hydroxyl value and molecular weight (in cases of fatty and PEG bases respectively). All formulations were relatively stable after 12 months. In vivo studies of all formulations exhibited double peak phenomena. PEG based formula (S8) showed significant higher Cmax (10.05±1 μg/ml) and AUC0-12 (58.313±3.9 µg.h/mL) than fatty bases and oral solution. In conclusion, rectal administration of S8 could be prepared as an alternative to the oral dosage form to improve bioavailability and overcome the first-pass metabolism.

Ranitidine rectal suppositories bioavailability

References (19)

  1. 1 Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems
  2. 2 Factors Affecting the Formation of Eutectic Solid Dispersions and Their Dissolution Behavior [DOI]
  3. 3 Colonic metabolism of ranitidine: implications for its delivery and absorption [DOI]
  4. 4 Biowaiver monographs for immediate release solid oral dosage forms: Ranitidine hydrochloride [DOI]
  5. 5 Floating granules of ranitidine hydrochloride-gelucire 43/01: Formulation optimization using factorial design [DOI]
  6. 6 An in vitro - in silico approach for the formulation and characterization of ranitidine gastroretentive delivery systems [DOI]
  7. 7 A Modified Two-Portion Absorption Model to Describe Double-Peak Absorption Profiles of Ranitidine [DOI]
  8. 8 Chitosan superporous hydrogel composite-based floating drug delivery system: A newer formulation approach [DOI]
  9. 9 The role of various surfactants on the release of salbutamol from suppositories [DOI]
  10. 10 Disposition of radiolabelled suppositories in humans [DOI]
  11. 11 Sex differences in excipient effects: Enhancement in ranitidine bioavailability in the presence of polyethylene glycol in male, but not female, rats [DOI]
  12. 12 Effect of administration route on the selective lymphatic delivery of cyclosporin A by lipid-surfactant mixed micelles. [DOI]
  13. 13 Optimization of Suppository Preparation Containing Sodium Laurate and Taurine That Can Safely Improve Rectal Absorption of Rebamipide [DOI]
  14. 14 Strong cation exchange resin for improving physicochemical properties and sustaining release of ranitidine hydrochloride [DOI]
  15. 15 Compartmental analysis of ranitidine doubled peak plasma profile after oral administration to healthy volunteers [DOI]
  16. 16 Salbutamol Sulfate Suppositories: Influence of Formulation on Physical Parameters and Stability [DOI]
  17. 17 Preparation and In vitro Evaluation of Naproxen Suppositories.
  18. 18 [Solubility of drugs as criterion for drug liberation from fat-like, galenic bases (Cetylium phthalicum, lasupol G) with reference to viscosity increasing adjuvant substances].
  19. 19 Encyclopedia of Toxicology [DOI]

Cited by 2

Studies of physico-chemical and pharmaco-technological parameters of bioflavonoids diosmin and hesperidin

Yelyzaveta Borko, I. Kovalevska · ScienceRise Pharmaceutical Science · 2019

Article metrics

Real usage data collected on this platform.

13

Page views

0

PDF downloads

6

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.